We create breakthrough products - in diagnostics, medical devices, nutrition and branded generic pharmaceuticals - that help you, your family and your community lead healthier lives, full of unlimited possibilities. Today, 115,000 of us are working to make a lasting impact on health in the more than 160 countries we serve.
Visit the ABBOTT LABORATORIES LIMITED website HERE
At Amgen, we believe in a "biology first" approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each and every one of us.
Visit the AMGEN LTD website HERE
At Boehringer Ingelheim we are driven by the desire to serve humankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our FOCUS articulates who we are and what we strive for, why we exist, how we work and what we want to achieve.
Visit the BOEHRINGER INGLEHEIM website HERE
As with every part of the Chiesi group, we embrace a shared set of values and a common code of ethical conduct. This demands the highest standards of reliability, transparency, and individual accountability, in everything we do. It emphasises the importance of collaborative working, putting people first and exchanging knowledge. Implicit in all of these values is a responsible attitude to the social and environmental impact of our actions and, in this regard, Chiesi was proud to achieve the B Corp certification in June 2019. This certification recognises our commitment to use business as a force for good, strive to ensure the business decisions and actions we take are sustainable, have regard to social and environmental considerations and involve fair and equitable treatment.
Visit the CHIESI LIMITED website HERE
GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.
Visit the GSK website HERE
FDB is the UK's leading supplier of clinical decision support and drug knowledge. Its solutions are integrated into healthcare systems across a wide range of settings, enabling evidence-based prescribing by providing essential checks to support clinicians. Its in-house team of expert clinicians check multiple sources and interpret NICE and other best practice resources to ensure that all medicines' information is up to date. Its position within the market means that FDB adopts new industry standards quickly and easily, while its clinical decision support can be fine-tuned to meet the needs of specialised environments to enhance clinical care, patient safety and quality.
Visit the FIRST DATABANK website HERE
We have been pioneering nutritional solutions since 1896, when our founders first began their early support of mothers and their infants. Since then, our nutritional solutions have transformed the lives of millions of people around the world. That pioneering spirit lives on today with an ongoing commitment to provide life-transforming nutrition at key moments throughout life.
Visit the NUTRICIA LTD website HERE
Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges.
Visit the ROSEMONT PHARMACEUTICALS LTD website HERE
PCPA: Send Hill Studios, Send Hill, Woking GU23 7HT
T: 0203 590 3943
E: info@pcpa.org.uk
This website uses cookies to ensure you get the best experience on our website. View our privacy policy and disclaimer.
